ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $525,308 | -8.7% | 20,560 | +2.5% | 0.00% | 0.0% |
| Q2 2023 | $575,321 | +109.4% | 20,060 | +75.0% | 0.00% | 0.0% |
| Q1 2023 | $274,696 | -22.8% | 11,460 | +53.9% | 0.00% | 0.0% |
| Q3 2021 | $356,000 | -96.8% | 7,444 | -97.7% | 0.00% | -96.0% |
| Q2 2021 | $11,015,000 | -32.1% | 325,493 | -17.1% | 0.02% | -40.5% |
| Q1 2021 | $16,219,000 | +129.2% | 392,703 | +140.8% | 0.04% | +110.0% |
| Q4 2020 | $7,075,000 | -40.3% | 163,090 | -41.0% | 0.02% | -52.4% |
| Q3 2020 | $11,854,000 | +173.4% | 276,318 | +197.9% | 0.04% | +100.0% |
| Q2 2020 | $4,335,000 | +1285.0% | 92,746 | +302.5% | 0.02% | +600.0% |
| Q1 2020 | $313,000 | -61.9% | 23,042 | -69.5% | 0.00% | +50.0% |
| Q4 2019 | $822,000 | +440.8% | 75,662 | +411.4% | 0.00% | +100.0% |
| Q3 2019 | $152,000 | – | 14,794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |